AzTrials
AzTrials

MyopiaNCT00009529

The Contact Lens and Myopia Progression (CLAMP) Study

An observational study of Myopia, run by National Eye Institute (NEI) at 1 site in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

To examine the effects of rigid gas permeable contact lenses on the progression of myopia (nearsightedness) in children To determine what changes in the eyes cause certain eyes to progress in nearsightedness more slowly Read more about this study

Who is it for?
Ages 8 to 11 years
Conditions the study is for
Myopia
How many people
Not given
Where
1 siteUnited States
Study dates
Start not givento not given
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 8 to 11 years
  • All sexes
  • No healthy volunteers
  • Child

Children with myopia who are able to adapt to rigid contact lens wear

Trial locations and contacts

1 site in 1 country.

United States1 site
  • The Ohio State University College of Optometry

    Columbus, Ohio, 43210

Other trials in United States

About this study

To examine the effects of rigid gas permeable contact lenses on the progression of myopia (nearsightedness) in children

To determine what changes in the eyes cause certain eyes to progress in nearsightedness more slowly

Read the detailed description

Rigid gas permeable (RGP) contact lenses provide clear, comfortable vision with relatively few ocular health risks and are a standard management option for correcting nearsightedness. While RGP contact lenses are used to correct myopic refractive error, they may also slow the progression of myopia. A definitive study that could provide guidance regarding the effects of rigid gas permeable contact lenses on myopia (nearsightedness) progression may define the standard of care for slowing the progression of myopia in young children.

An eye care practitioner first reported that hard contact lenses may slow or stop the progression of nearsightedness in 1956. Other anecdotal clinical reports with similar results soon followed. Previous review papers have suggested that rigid contact lenses slow the progression of myopia in children, and several studies have attempted to prove this.

Two studies in the past twenty years have shown that rigid gas permeable contact lenses slow the progression of nearsightedness in children, however both studies failed to provide proper attention to many important variables. While these earlier works produced intriguing results for scientists and clinicians, they contain many problems that challenge the significance of the studies findings. The faults of the previous studies can be summarized in four categories: 1) high losses to follow-up, 2) inadequate control group, 3) incomplete ocular component measurements, and 4) inadequate or poorly selected entry criteria.

Positive results in previous studies also failed to exclude alternate possibilities which may explain why rigid gas permeable contact lenses may slow the progression of myopia. For example, the studies found that rigid contact lenses slow the progression of myopia and that corneal flattening accounts for some of the treatment effect, but none of the studies was able to definitively answer other mechanisms that may slow myopia advancement. A need for a controlled study of rigid contact lenses which measures all of the components that may affect myopia progression still exists. The CLAMP Study examines all of these components and addresses the problems encountered in previous studies.

The CLAMP Study uses a run-in period to enroll only children who are able to adapt to rigid contact lens wear into the study. This decreases the number of children who drop-out of the study because they cannot adapt to rigid contact lens wear. Once children show that they are able to wear rigid contact lenses, they are enrolled in the study and randomly assigned to wear rigid gas permeable contact lenses or soft contact lenses. Both groups are then examined each year for three years to determine which group progresses the most in nearsightedness.

Annual examinations include assessment of the children's ability to focus their eyes, their eye glass prescription, the length of their eyes, detailed maps of the shape and thickness of their corneas (the clear window on the front of the eye), the shape of their eyes, and the curvature of the lens inside the eye. Their eye glass prescription is determined when the children's eyes are dilated. We examined 222 children for eligibility. Out of the 222 children, 148 were eligible to participate in the run-in period. Of the 148 eligible children, 116 (78.5%) were able to adapt to rigid gas permeable contact lens wear. All of the children were examined at The Ohio State University College of Optometry.

Conditions
Myopia
Medical subject headings
Myopia

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted29 Jan 2001 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
IDs, dates and publications
ClinicalTrials.gov ID
NCT00009529
Sponsor's protocol ID
NEI-81
Status last verified
Oct 2009
First submitted
27 Jan 2001
Last updated
16 Oct 2009
Results posted
No

Publications

  • Lawrenson JG, Shah R, Huntjens B, Downie LE, Virgili G, Dhakal R, Verkicharla PK, Li D, Mavi S, Kernohan A, Li T, Walline JJ. Interventions for myopia control in children: a living systematic review and network meta-analysis. Cochrane Database Syst Rev. 2023 Feb 16;2(2):CD014758. doi: 10.1002/14651858.CD014758.pub2.

    PubMed 36809645

Questions about this trial

What is this clinical trial studying?

An observational study of Myopia, run by National Eye Institute (NEI) at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 16 Oct 2009. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT00009529, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 16 Oct 2009.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in
The Contact Lens and Myopia Progression (CLAMP) Study | AzTrials